India: Eculizumab Approved by CDSCO for aHUS & PNH
After years of waiting, eculizumab Soliris(R) has been approved by India’s Central Drugs Standard Control Organisation (CDSCO) as an approved drug…
Spotlight on aHUS Research: Dec 2024
It’s been a busy 4th quarter to round out 2024 for our aHUS Alliance Global Action team, and we’d like to…
Página em Português da Comunidade de SHUa
Artigo Convidado: Pamela Notario Guest Article: by Pamela Notario (English Version below Portuguese Version) É com grande alegria que lançamos a…
AIRG Suisse: Their aHUS Survey
Our aHUS Alliance Global Action team takes to heart our mission to “Inform. Connect. Collaborate” on ideas and initiatives across all…
What’s New in aHUS Research: SEPT 2024 Edition
Every year since the first aHUS Awareness Day on 24 Sept 2015 we’ve attempted to shine a spotlight on atypical HUS…
Atypical HUS Facts: 2024 – Sept – 2025
2024 – SEPT – 2025 Atypical HUS: Fact Sheets & Research Atypical Hemolytic Uremic Syndrome – a Rare Disease Information…
aHUS Newsletter: Have you Seen our July 2024 Edition?
Where can you get aHUS news that’s independent, objective, and focused on what’s important to the atypical HUS community? Here! We’re…
2024 aHUS Awareness Day: Theme for the aHUS 24 Sept Campaign
The theme for aHUS Awareness Day 2024 is 'Mental Health'
2024 Global aHUS Poll Launches
2024 survey launched to explore atypical HUS patient experiences around the world.
- 1
- 2
- 3
- 4
- …
- 8
- Go to the next page